Lipocalin-2 promotes CKD vascular calcification by aggravating VSMCs ferroptosis through NCOA4/FTH1-mediated ferritinophagy
Yujia Wang, Yuxia Zhang, Min Gao, Zhiqing Chen, Jing Lu, Yongqi Li, Yan Di, Yinan Zhao, Bicheng Liu, Rining Tang · 2024
Read Lipocalin-2 promotes CKD vascular calcification by aggravating VSMCs ferroptosis through NCOA4/FTH1-mediated ferritinophagy by Yujia Wang, Yuxia Zhang, Min Gao, Zhiqing Chen, Jing Lu, Yongqi Li, Yan Di, Yinan Zhao, Bicheng Liu, Rining Tang (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11607329.txt.
Description
Yujia Wang and nine co-authors show that lipocalin-2 drives vascular calcification in chronic kidney disease by worsening an iron linked cell death pathway. Calcification of vessels is a common complication of kidney disease with no effective therapy. High phosphate, a hallmark of the disease, triggers ferroptosis in vessel muscle cells, and lipocalin-2 handles iron traffic in cells.
High phosphate raises lipocalin-2 in arteries of patients, animal models, and cultured cells. Mice lacking the gene show far less calcification on a disease diet, while added lipocalin-2 worsens calcium deposits and cell state change. The mechanism runs through a ferritin eating pathway that frees iron and drives ferroptosis. Blocking that axis eases calcification in the models.
Catalog record
| CREATOR | Yujia Wang, Yuxia Zhang, Min Gao, Zhiqing Chen, Jing Lu, Yongqi Li, Yan Di, Yinan Zhao, Bicheng Liu, Rining Tang |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 77 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |